Why schizophrenic patients use psychoactive substances?
Sawicka, M.
Psychiatria Polska 38(4): 723-726
2004
ISSN/ISBN: 0033-2674 PMID: 15518319 Document Number: 576071
In the article the problems of prevalence of schizophrenic disorders and comorbidity with psychoactive substances such as drugs and alcohol were presented. This review summarizes the recent literature concerning: personality, schizophrenia and coming to decision to use psychoactive substances such as drugs and alcohol.
Document emailed within 1 workday
Related Documents
Gerová, Z.; Opatrný, K.; Sedivec, V.; Dzúrik, R. 1979: Plasma middle molecular substances (MMS) in schizophrenic patients International Journal of Artificial Organs 2(6): 327-328Vavrinková, B. 2011: Use of psychoactive substances and risk sexual behavior Ceska Gynekologie 76(1): 56-59
De Jong, C.A.J.; de Kanter, W. 2014: Commerce and psychoactive substances: beware Greeks bearing gifts Nederlands Tijdschrift Voor Geneeskunde 158: A8380
Wierzejska, R. 2014: Designer drugs and caffeine - characteristics of psychoactive substances and their impact on the organism Developmental Period Medicine 18(3): 394-399
Míguez, H.A.; Grimson, R.W. 1989: Emergency consultations for abuse of psychoactive substances in Buenos Aires hospitals Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 107(4): 296-306
Pach, J.; Gawlikowski, T.; Motyka, E.; Szkolnicka, B.; Hydzik, P. 1997: Acute poisoning with psychoactive substances among adult abusers of the Krakow population Przeglad Lekarski 54(6): 392-398
Majdanik, Sławomir.; Potocka-Banaś, B.; Borowiak, K. 2013: A rare case of exposure to natural psychoactive substances, and difficulties with medicolegal assessment Annales Academiae Medicae Stetinensis 59(1): 58-60
Pinchuk, P.V.; Kirichek, A.V.; Shabalina, A.E.; Smirnov, A.V.; Petukhov, A.E. 2016: Peculiarities of chemico-toxicological analysis of biological material aimed to detection of narcotic and psychoactive substances misuse by servicemen Voenno-Meditsinskii Zhurnal 337(2): 54-58
Bralet, M.C.; Yon, V.; Loas, G.; Noisette, C. 2000: Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients L'Encephale 26(6): 32-41
Modrzejewska, R. 2010: Comorbidity in adolescence: simultaneous declaration of depressive, eating, obsessive-compulsive symptoms and use of psychoactive substances in the general population of 17 year old students in a big city Psychiatria Polska 44(5): 651-663
Mazur, J.; Małkowska-Szkutnik, A.; Tabak, I. 2012: The relationship between casual paid work, the use of psychoactive substances and school problems among upper secondary school students Przeglad Lekarski 69(10): 867-871
Rojek, S.; Kłys, Młgorzata.; Konopka, T. 2009: Application of hair analysis of selected psychoactive substances for medico-legal purposes. Part I. Segmental hair analysis in cases of fatal opioids and amphetamines poisoning Archiwum Medycyny Sadowej i Kryminologii 59(4): 273-278
Achong, M.R.; Bayne, J.R.; Gerson, L.W.; Golshani, S. 1978: Prescribing of psychoactive drugs for chronically ill elderly patients Canadian Medical Association Journal 118(12): 1503-1508
Acuda, S.W.; Sebit, M.B. 1997: Prevalence of psychoactive substance use among psychiatric in-patients in Harare, Zimbabwe Central African Journal of Medicine 43(8): 226-229
Khuwaja, A.K.; Ali, N.S.; Zafar, A.M. 2007: Use of psychoactive drugs among patients visiting outpatient clinics in Karachi, Pakistan Singapore Medical Journal 48(6): 509-513
Chrostek Maj, J.; Kroch, Sław.; Kamenczak, A.; Polewka, A.; Szerszeń-Motyka, J. 2004: Assessment of disorders after chronic psychoactive drug abuse in patients hospitalized in detoxification units Przeglad Lekarski 61(4): 317-319
Eninia, G.I.; Smeltere, E.S.; Godlevska, M.A. 1981: Effect of a number of psychoactive agents on indices of cerebral circulation in patients with chronic cerebrovascular insufficiency Klinicheskaia Meditsina 59(9): 42-45
Nakano, S.; Onishi, K.; Onakado, H. 1988: On the discharge of schizophrenic patients--the status of families accepting the patients Nursing Technique 34(7): 838-848
Azorin, J.M.; Bovier, P.; Widmer, J.; Tissot, R.; Jeanningros, R. 1992: Erythrocyte membrane transport of amino acid precursors of monoamines in schizophrenic patients. Comparison with depressive patients L'Encephale 18(5): 585-590
Bogers, J.P.; de Jong, J.T. 1998: High incidence of admissions for schizophrenia in Surinam patients in the Netherlands not caused by preferential immigration of (pre)schizophrenic patients Nederlands Tijdschrift Voor Geneeskunde 142(9): 464-468